Biopolymer-Based Multilayer Microparticles for Probiotic Delivery to Colon

Sepehr Talebian1,2, Timothy Schofield1, Peter Valtchev1,3

  • 1School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.

Insights

Multilayer encapsulation using biopolymers enhances probiotic survival during storage and digestion. This advanced technique offers superior protection compared to single-layer methods for improved health benefits.

Area of Science:

  • Food Science
  • Biotechnology
  • Materials Science

Background:

  • Probiotic viability is crucial for health benefits but is compromised during food storage and gastrointestinal transit.
  • Microencapsulation using biopolymers is a key strategy to protect probiotics, but single-layer approaches have limitations.

Purpose of the Study:

  • To review emerging multilayer encapsulation methods for probiotics using biopolymers.
  • To correlate fabrication techniques with microparticle properties and categorize multilayer designs.
  • To examine recent biopolymeric formulations and their performance in animal models.

Main Methods:

  • Review of scientific literature on multilayer microencapsulation of probiotics.
  • Analysis of biopolymer properties and fabrication techniques.
  • Evaluation of physical and biological properties of multilayer microparticles.

Main Results:

  • Multilayer encapsulation significantly improves probiotic resistance to environmental stresses.
  • Different layer designs and fabrication methods yield varied microparticle characteristics.
  • Promising results observed in animal models for gastrointestinal transit and disease.

Conclusions:

  • Multilayer biopolymer encapsulation represents a significant advancement for probiotic delivery.
  • Novel materials and fabrication approaches are emerging for enhanced probiotic protection.
  • This strategy holds potential for realizing the full health benefits of probiotics.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Bioplastics01:27

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...